JP2020518563A5 - - Google Patents

Download PDF

Info

Publication number
JP2020518563A5
JP2020518563A5 JP2019558348A JP2019558348A JP2020518563A5 JP 2020518563 A5 JP2020518563 A5 JP 2020518563A5 JP 2019558348 A JP2019558348 A JP 2019558348A JP 2019558348 A JP2019558348 A JP 2019558348A JP 2020518563 A5 JP2020518563 A5 JP 2020518563A5
Authority
JP
Japan
Prior art keywords
compound according
group
heteroaryl
aryl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2019558348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020518563A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/030300 external-priority patent/WO2018204286A1/en
Publication of JP2020518563A publication Critical patent/JP2020518563A/ja
Publication of JP2020518563A5 publication Critical patent/JP2020518563A5/ja
Withdrawn legal-status Critical Current

Links

JP2019558348A 2017-04-30 2018-04-30 抗ガン幹細胞性薬物 Withdrawn JP2020518563A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762492284P 2017-04-30 2017-04-30
US62/492,284 2017-04-30
PCT/US2018/030300 WO2018204286A1 (en) 2017-04-30 2018-04-30 An anti-cancer stemness drug

Publications (2)

Publication Number Publication Date
JP2020518563A JP2020518563A (ja) 2020-06-25
JP2020518563A5 true JP2020518563A5 (https=) 2021-06-17

Family

ID=64016246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019558348A Withdrawn JP2020518563A (ja) 2017-04-30 2018-04-30 抗ガン幹細胞性薬物

Country Status (6)

Country Link
US (1) US20200062738A1 (https=)
EP (1) EP3618831A4 (https=)
JP (1) JP2020518563A (https=)
CN (1) CN111093659A (https=)
TW (1) TW201841888A (https=)
WO (1) WO2018204286A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110105260B (zh) * 2019-06-11 2020-10-30 中山大学 芳环脲基吲哚衍生物及其制备方法和应用
CN115353512B (zh) * 2021-07-30 2025-07-08 上海翊石医药科技有限公司 一种杂环脲类化合物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504401B2 (en) * 2003-08-29 2009-03-17 Locus Pharmaceuticals, Inc. Anti-cancer agents and uses thereof
CA2951295C (en) * 2007-04-16 2020-04-28 Abbvie Inc. 7-nonsubstituted indole mcl-1 inhibitors
WO2015076800A1 (en) * 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
CN106456602B (zh) * 2014-03-27 2020-11-24 范德比尔特大学 取代的吲哚mcl-1抑制剂

Similar Documents

Publication Publication Date Title
RU2500680C2 (ru) Новые замещенные пиридин-2-оны и пиридазин-3-оны
JP2016531121A5 (https=)
RU2021139070A (ru) Ингибиторы ERBB/BTK
RU2010136665A (ru) Новые пиридиноны и пиридазиноны
RU2012108629A (ru) Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
NO20042584L (no) Dibenzylaminforbindelser og farmasoytisk anvendelse derav
NZ585701A (en) Benzopyrazine derivatives as prolyl hydroxylase inhibitors
JP2009537469A5 (https=)
JP2012508252A5 (https=)
JP2010511721A5 (https=)
RU2014140735A (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[1, 5-a]ПИРИМИДИНА, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2015143283A5 (https=)
RU2009140324A (ru) Получение фталоцианинов кремния и германия и родственных субстанций
JP2015534574A5 (https=)
JP2015500795A5 (https=)
JP2017536416A5 (https=)
JP2020063289A5 (https=)
TR201809990T4 (en) NEW COMPOSITIONS, USES AND METHODS FOR THEIR MAKING.
JP2015522650A5 (https=)
JP2014524441A5 (https=)
RU2012109554A (ru) Лиганды сигма-рецепторов для предупреждения или лечения боли, вызванной химиотерапией
TW200612920A (en) Novel imidazolidine derivatives
MX2022002362A (es) Derivado de 2-aminoquinazolinona.
JP2020518563A5 (https=)
JP2024112835A5 (https=)